# Amkor Technology, Inc.: financial statements, quarterly

AMKR · Nasdaq · CIK 1047127 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amkr.md) · [Financials](/companies/amkr/financials.md) · [Filings](/companies/amkr/filings.md) · [Insiders](/companies/amkr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amkr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,458](/filings/0001047127-24-000159.md) | [1,822](/filings/0001047127-24-000203.md) | [1,752 d](/filings/0001047127-26-000014.md) | [1,366](/filings/0001047127-25-000087.md) | [1,461](/filings/0001047127-25-000168.md) | [1,862](/filings/0001047127-25-000190.md) | [1,629 d](/filings/0001047127-26-000014.md) | [1,322](/filings/0001047127-26-000020.md) | [1,511](/filings/0001047127-25-000168.md) | [1,987](/filings/0001047127-25-000190.md) | [1,888 d](/filings/0001047127-26-000014.md) | [1,685](/filings/0001047127-26-000020.md) |
| Cost of revenue | $m | [1,271](/filings/0001047127-24-000159.md) | [1,539](/filings/0001047127-24-000203.md) | [1,473 d](/filings/0001047127-26-000014.md) | [1,164](/filings/0001047127-25-000087.md) | [1,249](/filings/0001047127-25-000168.md) | [1,589](/filings/0001047127-25-000190.md) | [1,382 d](/filings/0001047127-26-000014.md) | [1,164](/filings/0001047127-26-000020.md) | [1,329](/filings/0001047127-25-000168.md) | [1,702](/filings/0001047127-25-000190.md) | [1,573 d](/filings/0001047127-26-000014.md) | [1,446](/filings/0001047127-26-000020.md) |
| Gross profit | $m | [187](/filings/0001047127-24-000159.md) | [283](/filings/0001047127-24-000203.md) | [279 d](/filings/0001047127-26-000014.md) | [202](/filings/0001047127-25-000087.md) | [212](/filings/0001047127-25-000168.md) | [272](/filings/0001047127-25-000190.md) | [247 d](/filings/0001047127-26-000014.md) | [158](/filings/0001047127-26-000020.md) | [182](/filings/0001047127-25-000168.md) | [284](/filings/0001047127-25-000190.md) | [315 d](/filings/0001047127-26-000014.md) | [239](/filings/0001047127-26-000020.md) |
| Research and development | $m | [45.7](/filings/0001047127-24-000159.md) | [43.1](/filings/0001047127-24-000203.md) | [41.6 d](/filings/0001047127-26-000014.md) | [38.2](/filings/0001047127-25-000087.md) | [39.6](/filings/0001047127-25-000168.md) | [42.4](/filings/0001047127-25-000190.md) | [42.8 d](/filings/0001047127-26-000014.md) | [45.7](/filings/0001047127-26-000020.md) | [42.0](/filings/0001047127-25-000168.md) | [42.4](/filings/0001047127-25-000190.md) | [36.7 d](/filings/0001047127-26-000014.md) | [41.8](/filings/0001047127-26-000020.md) |
| Selling, general and administrative | $m | [64.9](/filings/0001047127-24-000159.md) | [73.0](/filings/0001047127-24-000203.md) | [78.8 d](/filings/0001047127-26-000014.md) | [90.3](/filings/0001047127-25-000087.md) | [91.3](/filings/0001047127-25-000168.md) | [80.8](/filings/0001047127-25-000190.md) | [69.4 d](/filings/0001047127-26-000014.md) | [80.4](/filings/0001047127-26-000020.md) | [47.9](/filings/0001047127-25-000168.md) | [83.2](/filings/0001047127-25-000190.md) | [92.9 d](/filings/0001047127-26-000014.md) | [97.0](/filings/0001047127-26-000020.md) |
| Operating income | $m | [76.3](/filings/0001047127-24-000159.md) | [167](/filings/0001047127-24-000203.md) | [159 d](/filings/0001047127-26-000014.md) | [73.1](/filings/0001047127-25-000087.md) | [81.5](/filings/0001047127-25-000168.md) | [149](/filings/0001047127-25-000190.md) | [134 d](/filings/0001047127-26-000014.md) | [31.5](/filings/0001047127-26-000020.md) | [92.0](/filings/0001047127-25-000168.md) | [159](/filings/0001047127-25-000190.md) | [185 d](/filings/0001047127-26-000014.md) | [100](/filings/0001047127-26-000020.md) |
| Interest expense | $m | [14.4](/filings/0001047127-23-000024.md) | [13.0](/filings/0001047127-23-000030.md) | [15.5 d](/filings/0001047127-24-000019.md) | [16.4](/filings/0001047127-24-000094.md) | [15.8](/filings/0001047127-25-000168.md) | [15.6](/filings/0001047127-25-000190.md) | [17.1 d](/filings/0001047127-26-000014.md) | [16.8](/filings/0001047127-26-000020.md) | [16.8](/filings/0001047127-25-000168.md) | [21.2](/filings/0001047127-25-000190.md) | [20.6 d](/filings/0001047127-26-000014.md) | [17.7](/filings/0001047127-26-000020.md) |
| Income tax | $m | [9.4](/filings/0001047127-24-000159.md) | [28.9](/filings/0001047127-24-000203.md) | [32.5 d](/filings/0001047127-26-000014.md) | [12.2](/filings/0001047127-25-000087.md) | [14.3](/filings/0001047127-25-000168.md) | [19.2](/filings/0001047127-25-000190.md) | [29.8 d](/filings/0001047127-26-000014.md) | [3.9](/filings/0001047127-26-000020.md) | [28.2](/filings/0001047127-25-000168.md) | [27.7](/filings/0001047127-25-000190.md) | [8.7 d](/filings/0001047127-26-000014.md) | [12.3](/filings/0001047127-26-000020.md) |
| Net income | $m | [64.3](/filings/0001047127-24-000159.md) | [133](/filings/0001047127-24-000203.md) | [118 d](/filings/0001047127-26-000014.md) | [58.9](/filings/0001047127-25-000087.md) | [66.9](/filings/0001047127-25-000168.md) | [123](/filings/0001047127-25-000190.md) | [106 d](/filings/0001047127-26-000014.md) | [21.1](/filings/0001047127-26-000020.md) | [54.4](/filings/0001047127-25-000168.md) | [127](/filings/0001047127-25-000190.md) | [172 d](/filings/0001047127-26-000014.md) | [83.4](/filings/0001047127-26-000020.md) |
| Diluted EPS | $ per share | [0.26](/filings/0001047127-24-000159.md) | [0.54](/filings/0001047127-24-000203.md) | not reported | [0.24](/filings/0001047127-25-000087.md) | [0.27](/filings/0001047127-25-000168.md) | [0.49](/filings/0001047127-25-000190.md) | not reported | [0.09](/filings/0001047127-26-000020.md) | [0.22](/filings/0001047127-25-000168.md) | [0.51](/filings/0001047127-25-000190.md) | not reported | [0.33](/filings/0001047127-26-000020.md) |
| Basic EPS | $ per share | [0.26](/filings/0001047127-24-000159.md) | [0.54](/filings/0001047127-24-000203.md) | not reported | [0.24](/filings/0001047127-25-000087.md) | [0.27](/filings/0001047127-25-000168.md) | [0.50](/filings/0001047127-25-000190.md) | not reported | [0.09](/filings/0001047127-26-000020.md) | [0.22](/filings/0001047127-25-000168.md) | [0.51](/filings/0001047127-25-000190.md) | not reported | [0.34](/filings/0001047127-26-000020.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [805](/filings/0001047127-23-000024.md) | [736](/filings/0001047127-23-000030.md) | [1,120](/filings/0001047127-25-000030.md) | [1,118](/filings/0001047127-24-000094.md) | [1,080](/filings/0001047127-24-000159.md) | [959](/filings/0001047127-24-000203.md) | [1,134](/filings/0001047127-26-000014.md) | [1,058](/filings/0001047127-25-000087.md) | [1,527](/filings/0001047127-25-000168.md) | [1,496](/filings/0001047127-25-000190.md) | [1,378](/filings/0001047127-26-000020.md) | [1,121](/filings/0001047127-26-000020.md) |
| Current assets | $m | [2,999](/filings/0001047127-23-000024.md) | [3,126](/filings/0001047127-23-000030.md) | [3,196](/filings/0001047127-25-000030.md) | [3,045](/filings/0001047127-24-000094.md) | [3,137](/filings/0001047127-24-000159.md) | [3,244](/filings/0001047127-24-000203.md) | [3,073](/filings/0001047127-26-000014.md) | [2,991](/filings/0001047127-25-000087.md) | [3,625](/filings/0001047127-25-000168.md) | [4,008](/filings/0001047127-25-000190.md) | [3,885](/filings/0001047127-26-000020.md) | [3,752](/filings/0001047127-26-000020.md) |
| Total assets | $m | [6,638](/filings/0001047127-23-000024.md) | [6,735](/filings/0001047127-23-000030.md) | [6,771](/filings/0001047127-25-000030.md) | [6,685](/filings/0001047127-25-000087.md) | [6,866](/filings/0001047127-24-000159.md) | [7,029](/filings/0001047127-24-000203.md) | [6,944](/filings/0001047127-26-000014.md) | [6,921](/filings/0001047127-25-000087.md) | [7,706](/filings/0001047127-25-000168.md) | [8,187](/filings/0001047127-25-000190.md) | [8,136](/filings/0001047127-26-000020.md) | [8,299](/filings/0001047127-26-000020.md) |
| Current liabilities | $m | [1,576](/filings/0001047127-23-000024.md) | [1,602](/filings/0001047127-23-000030.md) | [1,384](/filings/0001047127-25-000030.md) | [1,303](/filings/0001047127-24-000094.md) | [1,507](/filings/0001047127-24-000159.md) | [1,573](/filings/0001047127-24-000203.md) | [1,455](/filings/0001047127-26-000014.md) | [1,454](/filings/0001047127-25-000087.md) | [1,916](/filings/0001047127-25-000168.md) | [2,261](/filings/0001047127-25-000190.md) | [1,712](/filings/0001047127-26-000020.md) | [1,867](/filings/0001047127-26-000020.md) |
| Total liabilities | $m | [2,875](/filings/0001047127-23-000024.md) | [2,857](/filings/0001047127-23-000030.md) | [2,776](/filings/0001047127-25-000030.md) | [2,654](/filings/0001047127-24-000094.md) | [2,782](/filings/0001047127-24-000159.md) | [2,832](/filings/0001047127-24-000203.md) | [2,761](/filings/0001047127-26-000014.md) | [2,731](/filings/0001047127-25-000087.md) | [3,474](/filings/0001047127-25-000168.md) | [3,845](/filings/0001047127-25-000190.md) | [3,630](/filings/0001047127-26-000020.md) | [3,729](/filings/0001047127-26-000020.md) |
| Long-term debt | $m | [976](/filings/0001047127-23-000024.md) | [947](/filings/0001047127-23-000030.md) | [1,072](/filings/0001047127-25-000030.md) | [1,038](/filings/0001047127-24-000094.md) | [949](/filings/0001047127-24-000159.md) | [894](/filings/0001047127-24-000203.md) | [923](/filings/0001047127-26-000014.md) | [913](/filings/0001047127-25-000087.md) | [1,198](/filings/0001047127-25-000168.md) | [1,265](/filings/0001047127-25-000190.md) | [1,283](/filings/0001047127-26-000020.md) | [1,257](/filings/0001047127-26-000020.md) |
| Current portion of debt | $m | [156](/filings/0001047127-23-000024.md) | [150](/filings/0001047127-23-000030.md) | [132](/filings/0001047127-25-000030.md) | [113](/filings/0001047127-24-000094.md) | [154](/filings/0001047127-24-000159.md) | [208](/filings/0001047127-24-000203.md) | [236](/filings/0001047127-26-000014.md) | [236](/filings/0001047127-25-000087.md) | [375](/filings/0001047127-25-000168.md) | [547](/filings/0001047127-25-000190.md) | [162](/filings/0001047127-26-000020.md) | [157](/filings/0001047127-26-000020.md) |
| Shareholders' equity | $m | [3,732](/filings/0001047127-23-000024.md) | [3,847](/filings/0001047127-23-000030.md) | [3,962](/filings/0001047127-25-000030.md) | [3,997](/filings/0001047127-24-000094.md) | [4,050](/filings/0001047127-24-000159.md) | [4,164](/filings/0001047127-24-000203.md) | [4,150](/filings/0001047127-26-000014.md) | [4,156](/filings/0001047127-25-000087.md) | [4,197](/filings/0001047127-25-000168.md) | [4,308](/filings/0001047127-25-000190.md) | [4,471](/filings/0001047127-26-000020.md) | [4,534](/filings/0001047127-26-000020.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [247 d](/filings/0001047127-24-000159.md) | [274 d](/filings/0001047127-24-000203.md) | [574 d](/filings/0001047127-26-000014.md) | [162](/filings/0001047127-25-000087.md) | [225 d](/filings/0001047127-25-000168.md) | [164 d](/filings/0001047127-25-000190.md) | [538 d](/filings/0001047127-26-000014.md) | [24.1](/filings/0001047127-26-000020.md) | [258 d](/filings/0001047127-25-000168.md) | [169 d](/filings/0001047127-25-000190.md) | [644 d](/filings/0001047127-26-000014.md) | [145](/filings/0001047127-26-000020.md) |
| Capital expenditure | $m | [184 d](/filings/0001047127-24-000159.md) | [229 d](/filings/0001047127-24-000203.md) | [238 d](/filings/0001047127-26-000014.md) | [96.2](/filings/0001047127-25-000087.md) | [166 d](/filings/0001047127-25-000168.md) | [196 d](/filings/0001047127-25-000190.md) | [286 d](/filings/0001047127-26-000014.md) | [79.9](/filings/0001047127-26-000020.md) | [146 d](/filings/0001047127-25-000168.md) | [246 d](/filings/0001047127-25-000190.md) | [432 d](/filings/0001047127-26-000014.md) | [225](/filings/0001047127-26-000020.md) |
| Dividends paid | $m | [18.4 d](/filings/0001047127-24-000159.md) | [18.5 d](/filings/0001047127-24-000203.md) | [19.4 d](/filings/0001047127-26-000014.md) | [19.4](/filings/0001047127-25-000087.md) | [19.4 d](/filings/0001047127-25-000168.md) | [19.4 d](/filings/0001047127-25-000190.md) | [120 d](/filings/0001047127-26-000014.md) | [0.0](/filings/0001047127-26-000020.md) | [40.9 d](/filings/0001047127-25-000168.md) | [20.4 d](/filings/0001047127-25-000190.md) | [20.6 d](/filings/0001047127-26-000014.md) | [20.7](/filings/0001047127-26-000020.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [246](/filings/0001047127-23-000024.md) | [246](/filings/0001047127-23-000030.md) | [247](/filings/0001047127-24-000094.md) | [247](/filings/0001047127-24-000159.md) | [247](/filings/0001047127-24-000203.md) | [248](/filings/0001047127-25-000087.md) | [248](/filings/0001047127-25-000168.md) | [248](/filings/0001047127-25-000190.md) | [248](/filings/0001047127-26-000020.md) | [248](/filings/0001047127-25-000168.md) | [248](/filings/0001047127-25-000190.md) | [250](/filings/0001047127-26-000020.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 247,872,518 at 2026-04-21, from the cover of the [10-Q filed 2026-04-28](/filings/0001047127-26-000020.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.